Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Dec;62(12):5255–5260. doi: 10.1128/iai.62.12.5255-5260.1994

Virulence studies of Aspergillus nidulans mutants requiring lysine or p-aminobenzoic acid in invasive pulmonary aspergillosis.

C M Tang 1, J M Smith 1, H N Arst Jr 1, D W Holden 1
PMCID: PMC303262  PMID: 7960102

Abstract

To identify steps in fungal intermediary metabolism required by Aspergillus spp. during invasive pulmonary aspergillosis, we have developed murine models involving Aspergillus nidulans as the inoculum. The advantages of using A. nidulans over Aspergillus fumigatus or Aspergillus flavus, which are the most common agents of clinical disease, are the well-understood genetics of A. nidulans and a large range of mutants of this species which are affected in a variety of metabolic pathways. Comparison of the virulence of A. nidulans strains carrying mutations which block the biosynthesis of lysine (lysA2) and p-aminobenzoic acid (pabaA1) shows that lysA2 strains have reduced virulence while pabaA1 strains are entirely nonpathogenic. The pathogenicity of pabaA1 strains can be restored by supplementing the drinking water of animals with p-aminobenzoic acid. The results indicate that the availability of lysine in the lung is limited, and p-aminobenzoic acid is probably not available at all. Thus, models of invasive pulmonary aspergillosis involving A. nidulans can be used to identify metabolic pathways that may be essential for the pathogenicity of A. fumigatus, the predominant pathogenic species, suggesting potential new targets for antifungal therapy.

Full text

PDF
5255

Images in this article

5257Image
on p.5257
5258Image
on p.5258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arst H. N., Jr, Jones S. A., Bailey C. R. A method for the selection of deletion mutations in the L-proline catabolism gene cluster of Aspergillus nidulans. Genet Res. 1981 Oct;38(2):171–195. doi: 10.1017/s0016672300020516. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P. The emergence of fungi as major hospital pathogens. J Hosp Infect. 1988 Feb;11 (Suppl A):411–426. doi: 10.1016/0195-6701(88)90220-4. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413–437. doi: 10.1007/BF01964057. [DOI] [PubMed] [Google Scholar]
  4. Bujak J. S., Kwon-Chung K. J., Chusid M. J. Osteomyelitis and pneumonia in a boy with chronic granulomatous disease of childhood caused by a mutant strain of Aspergillus nidulans. Am J Clin Pathol. 1974 Mar;61(3):361–367. doi: 10.1093/ajcp/61.3.361. [DOI] [PubMed] [Google Scholar]
  5. Cove D. J. The induction and repression of nitrate reductase in the fungus Aspergillus nidulans. Biochim Biophys Acta. 1966 Jan 11;113(1):51–56. doi: 10.1016/s0926-6593(66)80120-0. [DOI] [PubMed] [Google Scholar]
  6. Denning D. W., Follansbee S. E., Scolaro M., Norris S., Edelstein H., Stevens D. A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991 Mar 7;324(10):654–662. doi: 10.1056/NEJM199103073241003. [DOI] [PubMed] [Google Scholar]
  7. Denning D. W., Stevens D. A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis. 1990 Nov-Dec;12(6):1147–1201. doi: 10.1093/clinids/12.6.1147. [DOI] [PubMed] [Google Scholar]
  8. Edman J. C., Goldstein A. L., Erbe J. G. Para-aminobenzoate synthase gene of Saccharomyces cerevisiae encodes a bifunctional enzyme. Yeast. 1993 Jun;9(6):669–675. doi: 10.1002/yea.320090613. [DOI] [PubMed] [Google Scholar]
  9. Garrad R. C., Bhattacharjee J. K. Lysine biosynthesis in selected pathogenic fungi: characterization of lysine auxotrophs and the cloned LYS1 gene of Candida albicans. J Bacteriol. 1992 Nov;174(22):7379–7384. doi: 10.1128/jb.174.22.7379-7384.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Green J. M., Merkel W. K., Nichols B. P. Characterization and sequence of Escherichia coli pabC, the gene encoding aminodeoxychorismate lyase, a pyridoxal phosphate-containing enzyme. J Bacteriol. 1992 Aug;174(16):5317–5323. doi: 10.1128/jb.174.16.5317-5323.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Green J. M., Nichols B. P. p-Aminobenzoate biosynthesis in Escherichia coli. Purification of aminodeoxychorismate lyase and cloning of pabC. J Biol Chem. 1991 Jul 15;266(20):12971–12975. [PubMed] [Google Scholar]
  12. Kirsch D. R., Whitney R. R. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect Immun. 1991 Sep;59(9):3297–3300. doi: 10.1128/iai.59.9.3297-3300.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Manning M., Snoddy C. B., Fromtling R. A. Comparative pathogenicity of auxotrophic mutants of Candida albicans. Can J Microbiol. 1984 Jan;30(1):31–35. doi: 10.1139/m84-005. [DOI] [PubMed] [Google Scholar]
  14. Minamoto G. Y., Barlam T. F., Vander Els N. J. Invasive aspergillosis in patients with AIDS. Clin Infect Dis. 1992 Jan;14(1):66–74. doi: 10.1093/clinids/14.1.66. [DOI] [PubMed] [Google Scholar]
  15. Purnell D. M. Virulence genetics of Aspergillus nidulans Eidam: a review. Mycopathologia. 1978 Dec 18;65(1-3):177–182. doi: 10.1007/BF00447188. [DOI] [PubMed] [Google Scholar]
  16. REDMOND A., CARRE I. J., BIGGART J. D., MACKENZIE D. W. ASPERGILLOSIS (ASPERGILLUS NIDULANS) INVOLVING BONE. J Pathol Bacteriol. 1965 Jan;89:391–395. doi: 10.1002/path.1700890147. [DOI] [PubMed] [Google Scholar]
  17. Sandhu D. K., Sandhu R. S., Khan Z. U., Damodaran V. N. Conditional virulence of a p-aminobenzoic acid-requiring mutant of Aspergillus fumigatus. Infect Immun. 1976 Feb;13(2):527–532. doi: 10.1128/iai.13.2.527-532.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shepherd M. G. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections. Infect Immun. 1985 Nov;50(2):541–544. doi: 10.1128/iai.50.2.541-544.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Smith J. M., Tang C. M., Van Noorden S., Holden D. W. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun. 1994 Dec;62(12):5247–5254. doi: 10.1128/iai.62.12.5247-5254.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tang C. M., Cohen J., Krausz T., Van Noorden S., Holden D. W. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun. 1993 May;61(5):1650–1656. doi: 10.1128/iai.61.5.1650-1656.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. White C. J., Kwon-Chung K. J., Gallin J. I. Chronic granulomatous disease of childhood. An unusual case of infection with Aspergillus nidulans var. echinulatus. Am J Clin Pathol. 1988 Sep;90(3):312–316. doi: 10.1093/ajcp/90.3.312. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES